Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Claire M Sathe, MD, Chester Poon, Debra M. M Sarasohn, MD, Leah Gilbert, Alok A Khorana, MD, Simon Mantha, MDMPH, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-142037

Published: 2020

Journal Articles

Prediction of COVID-19 Mortality in Patients with Cancer

Simon Mantha, MDMPH, Justin Jee, Gerald A. Soff, MD, Melissa S. Pessin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138576

Published: 2020

Journal Articles

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Simon Mantha, MDMPH, Andrew Dunbar, MD, Kelly L. Bolton, MD PhD, Sean Devlin, PhD, Dmitriy Gorenshteyn, PhD, Mark Donoghue, PhD, Maria E. Arcila, MD, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-138579

Published: 2020

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Gerald A. Soff, MD, Debra M. M Sarasohn, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jeanette Batista, RN, Jonathan Wills, Jodi V Mones, MD, Cy Wilkins, MD, Simon H Mantha, MD MPH

Blood (2018) 132 (Supplement 1): 2536.

https://doi.org/10.1182/blood-2018-99-115506

Published: 2018

Journal Articles

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Gerald A. Soff, MD, Jeanette Batista, RN, Debra M. M Sarasohn, MD, Jodi V Mones, MD, Cy Wilkins, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jonathan Wills, Simon H Mantha, MD MPH

Blood (2018) 132 (Supplement 1): 1252.

https://doi.org/10.1182/blood-2018-99-115538

Published: 2018

Journal Articles

Folate Testing and Deficiency in Hospitalized Cancer Patients

Zachary D. Epstein-Peterson, MD, Gerald A. Soff, MD, Maly Fenelus, MD, Deborah Korenstein, MD

Blood (2018) 132 (Supplement 1): 5814.

https://doi.org/10.1182/blood-2018-99-117073

Published: 2018

Journal Articles

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Valery J Li, MD, Yimei Miao, BS, Cy Wilkins, MD, Gerald A. Soff, MD

Blood (2017) 130 (Supplement 1): 2324.

https://doi.org/10.1182/blood.V130.Suppl_1.2324.2324

Published: 2017

Journal Articles

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Gerald A. Soff, MD, Yimei Miao, BS, Sean M. Devlin, PhD, Simon Mantha, MD MPH, Jodi V Mones, MD, Valery J Li, MD, Ghassan K Abou-Alfa, MD MBA, Andrea Cercek, MD, Nancy Kemeny, MD, Rekha Parameswaran, MD

Blood (2017) 130 (Supplement 1): 289.

https://doi.org/10.1182/blood.V130.Suppl_1.289.289

Published: 2017

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Simon Mantha, MD MPH, Gerald A. Soff, MD

Blood (2016) 128 (22): 2619.

https://doi.org/10.1182/blood.V128.22.2619.2619

Published: 2016

Journal Articles

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Eva Simona Laube, MD, Anthony Yu, MD, Dipti Gupta, MD MPH, Yimei Miao, BS, Patrick Samedy, MS, Jonathan Wills, BA, Stephen J. Harnicar, PharmD, BCOP, BCPS, Gerald A. Soff, MD, Simon Mantha, MD MPH

Blood (2016) 128 (22): 2621.

https://doi.org/10.1182/blood.V128.22.2621.2621

Published: 2016

Journal Articles

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Catherine C. Coombs, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Robert Siegelbaum, MD, Rekha Parameswaran, MD, Simon Mantha, MD MPH, Gerald A Soff, MD

Blood (2015) 126 (23): 1112.

https://doi.org/10.1182/blood.V126.23.1112.1112

Published: 2015

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Aiqi Dong, Sean Devlin, PhD, Simon Mantha, MD MPH, Rekha Parameswaran, MD, Gerald A Soff, MD

Blood (2015) 126 (23): 2068.

https://doi.org/10.1182/blood.V126.23.2068.2068

Published: 2015

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Simon Mantha, MD MPH, Yimei Miao, BS, Debra Sarasohn, MD, Jonathan Kessler, Rekha Parameswaran, MD, Samantha Stefanik, Gagandeep Brar, MD, Patrick Samedy, Jonathan Wills, Dhruvkumar Patel, Gerald A Soff, MD

Blood (2015) 126 (23): 431.

https://doi.org/10.1182/blood.V126.23.431.431

Published: 2015

Journal Articles

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Yimei Miao, BS, Gerald A Soff, MD, Rekha Parameswaran, MD, Jonathan Wills, Simon Mantha, MD MPH

Blood (2015) 126 (23): 429.

https://doi.org/10.1182/blood.V126.23.429.429

Published: 2015

Journal Articles

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Valkal Bhatt, PharmD, Leyla Shune, MD, Emily J Lauer, BS, BA, Marissa N Lubin, BA, Sean M. Devlin, PhD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio Giralt, MD, Rekha Parameswaran, MD, Miguel-Angel Perales, MD, Doris M. Ponce, MD, Gerald A. Soff, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1142.

https://doi.org/10.1182/blood.V124.21.1142.1142

Published: 2014

Journal Articles

Predicting Therapy-Related Acute Myeloid Leukemia By Routine Laboratory Values: An Analysis Of 126 Patients With Breast Cancer Referred For Bone Marrow Biopsy At Memorial Sloan-Kettering Cancer Center

Eytan M Stein, MD, Meier Hsu, Adam Goldrich, MD, Ashwin Kishtagari, MBBS, Sean M. Devlin, PhD, Martin S. Tallman, MD, Gerald A. Soff, MD, Rekha Parameswaran, MD

Blood (2013) 122 (21): 2661.

https://doi.org/10.1182/blood.V122.21.2661.2661

Published: 2013

Journal Articles

Identification Of Markers Of Thrombotic Risk and Response To Cytoreductive Intervention In Philadelphia-Chromosome Negative Myeloproliferative Neoplams

Gabriela Soriano Hobbs, MD, Minal Patel, Young Rock Chung, MSc, Omar Abdel-Wahab, MD, Gerald A. Soff, MD, Raajit K. Rampal, M.D., Ph.D.

Blood (2013) 122 (21): 3627.

https://doi.org/10.1182/blood.V122.21.3627.3627

Published: 2013

Journal Articles

Incidental Versus Symptomatic Pulmonary Embolism in Cancer Patients: A Multivariate Analysis of Recurrent VTE and Mortality.

Kathy Deng, MD, Rekha Parameswaran, MD, Benjamin P Soff, Gerald A. Soff, MD

Blood (2012) 120 (21): 2257.

https://doi.org/10.1182/blood.V120.21.2257.2257

Published: 2012

Journal Articles

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Rekha Parameswaran, MD, Gerald A. Soff, MD

Blood (2011) 118 (21): 1170.

https://doi.org/10.1182/blood.V118.21.1170.1170

Published: 2011

NARROW

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Prediction of COVID-19 Mortality in Patients with Cancer

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Folate Testing and Deficiency in Hospitalized Cancer Patients

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Predicting Therapy-Related Acute Myeloid Leukemia By Routine Laboratory Values: An Analysis Of 126 Patients With Breast Cancer Referred For Bone Marrow Biopsy At Memorial Sloan-Kettering Cancer Center

Identification Of Markers Of Thrombotic Risk and Response To Cytoreductive Intervention In Philadelphia-Chromosome Negative Myeloproliferative Neoplams

Incidental Versus Symptomatic Pulmonary Embolism in Cancer Patients: A Multivariate Analysis of Recurrent VTE and Mortality.

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only